Corcept Therapeutics Incorporated (NASDAQ:CORT) (MarketWatch)
Shares of Corcept Therapeutics Inc. CORT, -24.10% plunged 21% in premarket trade Monday, after the drug maker disclosed it was informed that Teva Pharmaceutical Industries Ltd. TEVA, -2.80% has submitted a new drug application (NDA) for a generic version of Corcept’s hyperglycemia treatment Korlym. The company said the notice letter it received alleges that the Korlym patents, with expiration dates August 2028 and August 2036, will not be infringed by Teva’s proposed product. Corcept said it intends to “vigorously defend” its intellectual property rights related to Korlym. Teva’s stock fell 2% ahead of the open.
Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) (Benzinga)
Eyegate Pharmaceuticals Inc shares tumbled 42.9 percent to $0.588 after the company announced that EGP-473 did not meet co-primary endpoints.
Arconic Inc (NYSE:ARNC) (Reuters)
(Reuters) – Arconic Inc (ARNC.N) forecast on Monday 2018 profit and free cash flow below Wall Street estimates as the specialty metal-parts maker spends more to ramp up production to meet rising demand for aircraft-engine components. Shares of the company, which said it was reviewing its businesses, fell as much as 8.6 percent to $26.60. “On the engine ramp, this is one of the biggest challenges that the aviation community has faced,” Chief Executive Officer Chip Blankenship said on a conference call.
Boeing Co (NYSE:BA) (CNBC)
Boeing – Boeing may be interested in bidding for a Canada jet fighter contract despite the ongoing trade dispute involving Canada’s Bombardier, according to a senior executive. Boeing has until February 9 to decide to bid. Separately, UPS placed an order for 14 747-8 freighters, easing doubts about that aircraft’s future.